Pfeiffer syndrome type 2 associated with a single amino acid deletion in the PGFR2 gene
M. Priolo,M. Lerone,M. Baffico,M. Baldi,R. Ravazzolo,A. Cama,V. Capra,M. Silengo
DOI: https://doi.org/10.1034/j.1399-0004.2000.580116.x
2000-07-01
Clinical Genetics
Abstract:To the Editor: Pfeiffer syndrome (PS) is an autosomal dominant disease characterised by coronal craniosynostosis, midface hypoplasia, broad thumbs and great toes, brachydactyly and a variable degree of syndactyly (1). PS type 2 patients have cloverleaf skull, severe proptosis, central nervous system involvement, broad and deviated thumbs and halluces. Prognosis is unfavourable with early death (2, 3). Mutations in FGFR1 and FGFR2 have been found in patients affected with PS. A single missense mutation in exon 5 of FGFR1 in the IgII–IgIII linker region causes familial PS (4). The mutations found in FGFR2 are missense in frame insertions or splice-site mutations (5–17). Two mutational hot spots have been identified in FGFR2 involving cysteine residues at codons 290 and 342, respectively (15). Different missense mutations at these codons have been found in patients affected with Crouzon syndrome, Jackson–Weiss syndrome and PS (15). One 18 bp in frame deletion has been found in a PS sporadic case (17). All the affected codons are located within the first segment of the Ig-like loop (IIIa) (17, 18) with the exception of the 342 codon. The patient reported here is affected with PS type 2 and carries an unknown mutation in FGFR2. He was admitted at 1 month of age to the Paediatric Neurosurgery Department because of craniofacial dysmorphism and neurological signs of intracranial hypertension. Severe acrocephalotrygonocephaly with cloverleaf skull, flat occipitus, downward displacement of the ears to a horizontal position with respect to the neck and severe ocular proptosis were noticed. Radial clinodactyly of the thumbs and valgus deviation of the halluces were also present. Computerised tomographic and magnetic resonance imaging investigations showed progressive triventricular hydrocephalus, callosal dysgenesis and Chiari I malformation. A cerebrospinal fluid ventriculo-peritoneal shunt was applied. Later, a cranioplastic was performed. Molecular analysis was performed on the FGFR2 DNA fragment encoding for the extracellular region containing the first half of the third Ig-like domain (IIIa) and a portion of the linker region between Ig-like domains I and III. Amplification of the relevant fragment by polymerase chain reaction (PCR) was performed using previously described primers (19), resulting in a 349-bp segment which contained FGFR2 exon 7 (IIIa). PCR products were sequenced directly in both directions by cycle sequencing method using a-33P radiolabelled dideoxynucleotides and the Thermo Sequenase Kit (Amersham Pharmacia Biotech, Milan, Italy). Sequencing analysis showed an ‘in frame’ 3-bp deletion (GAC), which removes the aspartic amino acid at position 273 (DD273). In order to confirm the result, ASO dot blot analysis by hybridisation was carried out (Fig. 1) according to standard procedures using the following g-32P end-labelled allele-specific oligonucleotides: 5%-CGG AGG AGA CGT AGA GTT T-Y as wild-type probe and 5%-CGG AGG AGT AGA GTT WT C-3% as mutant probe. Sequencing and ASO analysis were also performed on both parents, neither of whom carried the DD273. No ASO mutant cases were found in 60 control normal chromosomes. The present case is the first example of a minimal deletion affecting FGFR and associated with craniosynostosis. The deletion involves a negatively charged amino acid and is located in the IgII–IgIII linker region which consists of a sequence of 16 amino acids identical for all human fibroblast growth factor receptors highly conserved among different species (18, 20–22). The 273 aspartic acid is a highly conserved residue (18) and is very close to the first cysteine critical in the intramolecular bridge that defines the IgIIIl loop (18, 21, 23). The deletion of this single polar amino acid might affect the correct disulphide bridge formation, as previously hypothesised for the Phe276Val missense mutation (16) or, on the other hand, it might affect ligand binding (24). Single,